article · 2025
Glucagon-like Peptide-1 Receptor Agonists (GLP-1-RA) and GLP-1/Gastrointestinal Peptide RA (GLP-1/GIP-RA) Use in Adolescents and Young Adults with Type 1 Diabetes and Overweight or Obesity
Background: Many young people with type 1 diabetes have overweight or obesity (OW/OB). OW/OB increases risks of cardiovascular and kidney disease, leading ca...
1 citationsDOI: https://doi.org/10.1089/dtom.2025.0018Open access